WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Luzhou Laojiao Co., Ltd. vs Bio-Rad Laboratories, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Luzhou Laojiao Co., Ltd.

000568.SZ · Shenzhen Stock Exchange

Market cap (USD)$17.5B
Gross margin (TTM)85.4%
Operating margin (TTM)48.5%
Net margin (TTM)38%
SectorConsumer
IndustryBeer, wine and spirits
CountryCN
Data as of2026-08-23
73/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Luzhou Laojiao Co., Ltd.'s moat claims, evidence, and risks.

View 000568.SZ analysis

Bio-Rad Laboratories, Inc.

BIO · New York Stock Exchange

Market cap (USD)$10.4B
Gross margin (TTM)51.9%
Operating margin (TTM)9.1%
Net margin (TTM)8.6%
SectorHealthcare
IndustryMedical devices
CountryUS
Data as of2026-08-23
63/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.

View BIO analysis

Comparison highlights

  • Moat score gap: Luzhou Laojiao Co., Ltd. leads (73 / 100 vs 63 / 100 for Bio-Rad Laboratories, Inc.).
  • Segment focus: Luzhou Laojiao Co., Ltd. has 3 segments (87.9% in Mid- and high-end baijiu); Bio-Rad Laboratories, Inc. has 2 segments (61.3% in Clinical Diagnostics).
  • Moat breadth: Luzhou Laojiao Co., Ltd. has 2 moat types across 2 domains; Bio-Rad Laboratories, Inc. has 3 across 2.

Primary market context

Luzhou Laojiao Co., Ltd.

Mid- and high-end baijiu

Market

Mid- and high-priced baijiu in China, centered on strong-aroma products priced at least CNY150 per bottle

Geography

China (primarily); limited exports

Customer

Consumers buying for personal consumption, gifting, and banquets through distributors, retail, and e-commerce

Role

Distiller, owner of National Cellar 1573 and Luzhou Laojiao brands, and supplier to authorized distributors

Revenue share

87.9%

Bio-Rad Laboratories, Inc.

Clinical Diagnostics

Market

In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls

Geography

Global

Customer

Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories

Role

IVD OEM / installed-base consumables supplier (systems + kits + controls)

Revenue share

61.3%

Side-by-side metrics

Luzhou Laojiao Co., Ltd.
Bio-Rad Laboratories, Inc.
Ticker / Exchange
000568.SZ - Shenzhen Stock Exchange
BIO - New York Stock Exchange
Market cap (USD)
$17.5B
$10.4B
Gross margin (TTM)
85.4%
51.9%
Operating margin (TTM)
48.5%
9.1%
Net margin (TTM)
38%
8.6%
Sector
Consumer
Healthcare
Industry
Beer, wine and spirits
Medical devices
HQ country
CN
US
Primary segment
Mid- and high-end baijiu
Clinical Diagnostics
Market structure
Oligopoly
Oligopoly
Market share
n/a
9%-10% (implied)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
73 / 100
63 / 100
Moat domains
Demand, Supply
Supply, Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

No overlap yet.

Luzhou Laojiao Co., Ltd. strengths

Brand TrustPreferential Input Access

Bio-Rad Laboratories, Inc. strengths

Capex Knowhow ScaleInstalled Base ConsumablesSwitching Costs General

Segment mix

Luzhou Laojiao Co., Ltd. segments

Full profile >

Mid- and high-end baijiu

Oligopoly

87.9%

Other baijiu (mainstream/value)

Competitive

11.6%

Other revenues

Competitive

0.6%

Bio-Rad Laboratories, Inc. segments

Full profile >

Life Science

Competitive

38.7%

Clinical Diagnostics

Oligopoly

61.3%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.